Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. Elagolix
2. Orilissa
3. R-(+)-4-(2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2h-pyrimidin-1-yl)-1-phenylethylamino)butyrate
1. Elagolix Sodium Salt
2. 832720-36-2
3. Orlissa
4. Elagolix Sodium [usan]
5. Nbi-56418 Na
6. Nbi-56418-na
7. 832720-36-2 (sodium)
8. 5948vui423
9. Elagolix Sodium (usan)
10. Sodium (r)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-2,3-dihydropyrimidin-1(6h)-yl)-1-phenylethyl)amino)butanoate
11. Chembl502182
12. Sodium;4-[[(1r)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate
13. Unii-5948vui423
14. Nbi56418 Na
15. Orilissa (tn)
16. C32h29f5n3o5.na
17. Schembl1641994
18. Elagolix Sodium [who-dd]
19. Elagolix Sodium Salt [mi]
20. Dtxsid601003247
21. Ex-a2388
22. Mfcd12546649
23. Elagolix Sodium [orange Book]
24. Akos030524154
25. Nbi56418; Abt-620
26. Ccg-270333
27. Oriahnn Component Elagolix Sodium
28. Ac-29671
29. As-56299
30. Be163657
31. Hy-14369
32. Elagolix Sodium Component Of Oriahnn
33. Cs-0003317
34. D09336
35. Q27261650
36. 4-((r)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2h-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric Acid Sodium Salt
37. Butanoic Acid, 4-(((1r)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2h)-pyrimidinyl)-1- Phenylethyl)amino)-, Monosodium Salt
38. Butanoic Acid, 4-(((1r)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2h)-pyrimidinyl)-1-phenylethyl)amino)-, Monosodium Salt
39. Sodium 4-(((1r)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6- (trifluoromethyl)phenyl)methyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2h)-yl)-1- Phenylethyl)amino)butanoate
40. Sodium 4-(((1r)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2h)-yl)-1-phenylethyl)amino)butanoate
Molecular Weight | 653.6 g/mol |
---|---|
Molecular Formula | C32H29F5N3NaO5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 12 |
Exact Mass | 653.19250613 g/mol |
Monoisotopic Mass | 653.19250613 g/mol |
Topological Polar Surface Area | 102 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 1090 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Elagolix Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elagolix Sodium, including repackagers and relabelers. The FDA regulates Elagolix Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elagolix Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Elagolix Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Elagolix Sodium supplier is an individual or a company that provides Elagolix Sodium active pharmaceutical ingredient (API) or Elagolix Sodium finished formulations upon request. The Elagolix Sodium suppliers may include Elagolix Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Elagolix Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Elagolix Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Elagolix Sodium active pharmaceutical ingredient (API) in detail. Different forms of Elagolix Sodium DMFs exist exist since differing nations have different regulations, such as Elagolix Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Elagolix Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Elagolix Sodium USDMF includes data on Elagolix Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Elagolix Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Elagolix Sodium suppliers with USDMF on PharmaCompass.
A Elagolix Sodium written confirmation (Elagolix Sodium WC) is an official document issued by a regulatory agency to a Elagolix Sodium manufacturer, verifying that the manufacturing facility of a Elagolix Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Elagolix Sodium APIs or Elagolix Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Elagolix Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Elagolix Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Elagolix Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Elagolix Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Elagolix Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Elagolix Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Elagolix Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Elagolix Sodium suppliers with NDC on PharmaCompass.
Elagolix Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elagolix Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elagolix Sodium GMP manufacturer or Elagolix Sodium GMP API supplier for your needs.
A Elagolix Sodium CoA (Certificate of Analysis) is a formal document that attests to Elagolix Sodium's compliance with Elagolix Sodium specifications and serves as a tool for batch-level quality control.
Elagolix Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Elagolix Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elagolix Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Elagolix Sodium EP), Elagolix Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elagolix Sodium USP).
LOOKING FOR A SUPPLIER?